Nasdaq:US$15.70 (+0.49) | HKEX:HK$25.10 (+0.95) | AIM:£2.31 (+0.11)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases

1 items
a091030